Universe · entity
Octagon Capital Advisors LP
Institutional manager (13F) · CIK 1839435
13F holdings · as of 2026-03-31 · top 29 · reported portfolio $904M
| # | Issuer | Value | Shares |
|---|---|---|---|
| 1 | DIANTHUS THERAPEUTICS INC | $163M | 1,946,667 |
| 2 | COGENT BIOSCIENCES INC | $90M | 2,350,000 |
| 3 | ABIVAX SA | $75M | 677,000 |
| 4 | ALUMIS INC | $62M | 2,830,700 |
| 5 | DEFINIUM THERAPEUTICS INC | $46M | 2,440,000 |
| 6 | ARRIVENT BIOPHARMA INC | $45M | 1,971,054 |
| 7 | TAYSHA GENE THERAPIES INC | $40M | 8,859,911 |
| 8 | KYMERA THERAPEUTICS INC | $35M | 425,000 |
| 9 | MIRUM PHARMACEUTICALS INC | $31M | 338,900 |
| 10 | BIOAGE LABS INC | $31M | 1,748,000 |
| 11 | CENTESSA PHARMACEUTICALS PLC | $30M | 750,000 |
| 12 | KALVISTA PHARMACEUTICALS INC | $29M | 1,450,000 |
| 13 | XENON PHARMACEUTICALS INC | $28M | 490,000 |
| 14 | TERNS PHARMACEUTICALS INC | $28M | 530,000 |
| 15 | OCULAR THERAPEUTIX INC | $27M | 3,166,600 |
| 16 | PALISADE BIO INC | $18M | 10,276,317 |
| 17 | TREVI THERAPEUTICS INC | $18M | 1,485,000 |
| 18 | DISC MEDICINE INC | $17M | 270,000 |
| 19 | AKTIS ONCOLOGY INC | $17M | 960,847 |
| 20 | CONTEXT THERAPEUTICS INC | $14M | 5,250,000 |
| 21 | PRECISION BIOSCIENCES INC | $12M | 2,236,732 |
| 22 | DBV TECHNOLOGIES S A | $12M | 574,200 |
| 23 | UNICYCIVE THERAPEUTICS INC | $7M | 1,000,000 |
| 24 | BRIDGEBIO ONCOLOGY THERAPEUT | $6M | 719,000 |
| 25 | LEXEO THERAPEUTICS INC | $6M | 1,100,000 |
| 26 | PHARVARIS N V | $5M | 165,000 |
| 27 | PERSPECTIVE THERAPEUTICS INC | $3M | 791,555 |
| 28 | EVOMMUNE INC | $3M | 143,472 |
| 29 | GOSSAMER BIO INC | $3M | 7,750,000 |
Source: sec_edgar_13f · public regulatory · retrieved 2026-06-29. Public SEC data; no contact information.